🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized, multicenter, placebo-controlled, double-blind study will e...
Status
Completed
Location
Acorda Site #5020
Start Date
2014-11
Trial ID
NCT02240030
Treatments Being Tested
This study is a double-blind, randomized, placebo-controlled, 2-period, cro...
Status
Completed
Location
Site 002
Start Date
2015-12
Trial ID
NCT02633007
Treatments Being Tested
This is an open label, parallel group study to evaluate the pharmacokinetic...
Status
Completed
Location
Site 001
Start Date
2015-12
Trial ID
NCT02633839
This study will be an open-label, randomized, three-period cross-over pharm...
Status
Completed
Location
Site #001
Start Date
2016-06
Trial ID
NCT02812394
Treatments Being Tested
This study is a double-blind, randomized, placebo-controlled, 2-way crossov...
Status
Completed
Location
Site #9015
Start Date
2016-06
Trial ID
NCT02807675
Treatments Being Tested
This randomized, multicenter, placebo-controlled, double-blind study will e...
Status
Completed
Location
Civitas Investigational Site 1013
Start Date
2013-04
Trial ID
NCT01777555
This study is a 12-month, dose-level blinded, multicenter study of 2 inhale...
Status
Completed
Location
Acorda Site #5020
Start Date
2015-03
Trial ID
NCT02242487
Treatments Being Tested
This study is a 12-month, open-label, randomized, multicenter study which w...
Status
Completed
Location
Acorda Site #7145
Start Date
2015-03
Trial ID
NCT02352363
Treatments Being Tested
The purpose of this study is to determine the safety, efficacy and pharmaco...
Status
Completed
Location
Civitas Clinical Site #6
Start Date
2012-05
Trial ID
NCT01617135
Treatments Being Tested